Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Receivables - Net (2017 - 2025)

Historic Receivables - Net for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $252000.0.

  • ENvue Medical's Receivables - Net fell 5655.17% to $252000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $252000.0, marking a year-over-year decrease of 5655.17%. This contributed to the annual value of $98000.0 for FY2024, which is 6918.24% down from last year.
  • According to the latest figures from Q3 2025, ENvue Medical's Receivables - Net is $252000.0, which was down 5655.17% from $115000.0 recorded in Q2 2025.
  • Over the past 5 years, ENvue Medical's Receivables - Net peaked at $580000.0 during Q3 2024, and registered a low of $9000.0 during Q4 2022.
  • For the 5-year period, ENvue Medical's Receivables - Net averaged around $192210.5, with its median value being $134000.0 (2022).
  • Per our database at Business Quant, ENvue Medical's Receivables - Net tumbled by 9550.0% in 2022 and then surged by 343333.33% in 2023.
  • Quarter analysis of 5 years shows ENvue Medical's Receivables - Net stood at $200000.0 in 2021, then tumbled by 95.5% to $9000.0 in 2022, then surged by 3433.33% to $318000.0 in 2023, then plummeted by 69.18% to $98000.0 in 2024, then surged by 157.14% to $252000.0 in 2025.
  • Its last three reported values are $252000.0 in Q3 2025, $115000.0 for Q2 2025, and $358000.0 during Q1 2025.